Together with our own data showing also no radiosensitization by cetuximab in a panel of 5 HPV-positive HNSCC cell lines [30] and in agreement with other preclinical and recent clinical studies we conclude that EGFR inhibition is no effective strategy to increase the radiosensitivity of HNSCC cells. Here, EGFR is linked to head and neck squamous cell carcinoma.